12 reports of this reaction
2.7% of all AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE reports
#7 most reported adverse reaction
PRODUCT LOT NUMBER ISSUE is the #7 most commonly reported adverse reaction for AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE, manufactured by Kenvue Brands LLC. There are 12 FDA adverse event reports linking AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE to PRODUCT LOT NUMBER ISSUE. This represents approximately 2.7% of all 448 adverse event reports for this drug.
Patients taking AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE who experience product lot number issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT LOT NUMBER ISSUE is a less commonly reported adverse event for AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE, but still significant enough to appear in the safety profile.
In addition to product lot number issue, the following adverse reactions have been reported for AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE:
The following drugs have also been linked to product lot number issue in FDA adverse event reports:
PRODUCT LOT NUMBER ISSUE has been reported as an adverse event in 12 FDA reports for AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT LOT NUMBER ISSUE accounts for approximately 2.7% of all adverse event reports for AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE, making it a notable side effect.
If you experience product lot number issue while taking AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.